How Long Does a Patent Last and What Do Different Types Entail? An IP Lawyer Explains.

Trademark & IP Attorneys

Intellectual Property Attorneys

Your intellectual property rights are protected when you obtain a patent. But for how long?

‘How long does a patent last’ is a fairly common question and is difficult to get a straight answer for without seeking legal advice from a law firm or the U.S. patent office itself.”

— Alex R. Sluzas, Esq.

PHILADELPHIA, PENNSYLVANIA, UNITED STATES, July 31, 2018 /EINPresswire.com/ — There are two primary types of patent: U.S. utility patent and a design patent. According to the United States Patent and Trademark Office (USPTO) a utility patent is typically granted for 20 years from when the utility patent application is filed. The patent holder will have to pay periodic maintenance fees to sustain the enforceability of the patent. A design patent is generally granted protection for 14 years measured from the date the design patent is granted.

What is a Patent?

A patent is a term a new variety of people have questions about almost every day. While most people are aware that patents are an integral part of intellectual property rights, not everybody is aware of the facts or can even claim to know in depth what one is. According to Wikipedia, "A patent is a set of exclusive legal rights granted by a sovereign state or intergovernmental organization to an inventor or assignee for a limited period of time in exchange for detailed public disclosure of an invention. "

More Information About How Long a Patent Lasts

The news about the tech giant Apple winning a Patent infringement war over its rival Samsung made headlines in 2016. However, in this landmark patent issues litigation, Apple was only awarded about $120 million instead of the whopping $2.2 billion it originally claimed. The matter was decided by the courts in accordance with 'Section 289 of the US Patent Act.'

The exclusivity for the producing or using the concerned product that is patented, its process, or design is limited for a period of time. The details of patent protection are conveyed via a legal patent letter.

How long does a patent last’ is a fairly common question and is difficult to get a straight answer for without seeking legal advice from a law firm or the U.S. patent office itself. It is important to know about various kinds of intellectual property protection before you can find the correct reply to this subject matter. Remember that the law of the United States of America recognizes a number of different patents at present. Each of them remains valid for a stipulated period of time.

Before you are granted patent rights and become a patent owner, there are quite a few things to consider as you begin to understand how long are patents good for, including earliest filing date, non-provisional application versus provisional patent application, provisional filing date, patent extensions, public domain and any third parties IP rights.

Type of Patent

Knowing about the US Patent law happens to be the very first step to learn how long is a US patent good for. Each kind varies sharply depending on the nature of the patent. A design patent remains in force for as long as 14 to 15 years from the date that it had been granted the right. It depends on the date of filing as well. However, most individuals are interested in the utility kind when they expect an answer to the query of how long do patents last.

In the United States, a utility patent is granted for processes, compositions, and machines. This is also the most common type of patent filed and is valid for 20 years, which answers the most often asked question about the validity of a patent. However, the period is assessed from its first filing date. The matter gets intensely complicated if you have chosen to file for the patent multiple times.

Filing Date

The date of filing is all important here. Remember that each filing date is included in the records made available publicly. Going through the databases that are available to the public would give you access to the date that had been recorded by the patent office at the time of filing. It is easy to calculate the validity of the patent therefore once you are apprised of the filing date of a specific patent. Unfortunately, there is no restriction on filing and, a single patent can be filed on several occasions making the calculation slightly complicated.

Provisional Patents

Applying for a provisional patent is a common way of securing the filing for a utility patent. Think of it as the first step of the patent protection process. In fact, many companies, as well as individuals, opt for a provisional patent so as to include an informal provisional patent application on file. This will allow you a breather of up to a year.

You can use the time effectively to fine tune your products and machines. You are also welcome to find investors and create prototypes for your creations meanwhile. The process may be advantageous to a certain extent but comes with certain drawbacks as well.

The validity of your patent will be counted from the earliest date, i.e., the date of provisional application. The patent will be due to expire a year in advance, therefore. You must thus be sure of taking the right date into consideration while calculating the validity of the patent.

Pending Patents

Many people are familiar with the phrase "patent pending," but what does that actually mean?

The life of your patent is limited of course but the period of 20 years may be further reduced due to its pending status. The first filing date happens to be pivotal as the entire process will be hinged on it.

Although your patent remains valid from the date mentioned yet, you will not be able to enforce it until and unless the patent office issues it for you. Fortunately, you will be awarded a ‘patent term extension’ should an unnatural delay in claims occur due to a fault of the patent office.

If you've been searching for "patent lawyers near me" then look no further. Paul and Paul is the premier patent attorney you are looking for. We can help you with your patent questions and issues! Contact us today at (866) 975-7231 for a free case consultation.

+++++ Disclaimer+++++ This press release is considered advertising and does not constitute any client-attorney privilege and does not offer any advice or opinion on any legal matter. This release was drafted by Results Driven Marketing, LLC a digital marketing, Public Relations, advertising and content marketing firm located in Philadelphia, PA

Alex R. Sluzas, Esq.
Paul & Paul Intellectual Property Attorneys
215-568-4900
email us here


Source: EIN Presswire

Grandevo CG and Regalia CG Approved by the California Department of Pesticide Regulation

Regalia & Grandevo CG: Effective Tools for Controlling Economically Damaging Mites, Insect Pests and Plant Diseases and Boosting Yields and Quality for Cannabis

Marrone Bio Innovations (NASDAQ:MBII)

DAVIS, CA, USA, July 27, 2018 /EINPresswire.com/ — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that GRANDEVO CG and REGALIA CG have received label approval from the California Department of Pesticide Regulation, clearing the products for use on California Cannabis crops.

Both Grandevo CG and Regalia CG have active ingredients that have been designated as “exempt from the requirement of food tolerances” by the U.S. Environmental Protection Agency and have broadly defined crop use patterns listed on the DPR approved label that are interpreted as applicable for use on Cannabis.

GRANDEVO CG and REGALIA CG, effective, broad spectrum tools for pest control and improving crop quality and yields, are certified under the National Organic Program and listed by the Organic Materials Research Institute for use in organic gardening and farming. Both products have minimal re-entry intervals and pre-harvest intervals, meaning workers and home gardeners can quickly get back into their gardens or fields after applying the product and can safely apply it to their plants right up to the day of harvest.

The active ingredient in GRANDEVO CG is a new species of bacteria, Chromobacterium subtsugae, with both insecticidal and miticidal properties. The end product formulation of GRANDEVO CG contains no living Chromobacterium subtsugae cells and is also quality checked to ensure the product is free of harmful microbial contamination. Upon exposure to plant eating insects and mites, GRANDEVO CG stops pests from feeding in less than one minute and reduces adult insect and mite reproduction. Cannabis growers are readily adopting GRANDEVO CG to control bud mites and aphids, while home gardeners and small farmers use GRANDEVO CG to improve insect and mite control, such as plant-eating aphids, mites, beetles and caterpillars, in their gardens.

REGALIA CG is formulated with knotweed extract, which stimulates a plant’s own immune system, known as “induced systemic response” activity, to fight diseases while at the same time improving a plant’s growth, flower and fruit quantity, fruit and flower quality and overall crop yields, including Cannabis. In addition to its plant health, quality and yield enhancements, REGALIA CG controls powdery mildew, Botrytis, gray mold and leaf spot in treated plants.

GRANDEVO CG and REGALIA CG are available on Amazon, the MBI website and marronebio.com/cg and from selected distributors in one-quart and one-gallon containers.

“We are pleased to report that GRANDEVO CG and REGALIA CG meet the state’s criteria for use on Cannabis, as established by the California Department of Pesticide Regulation, and hope to receive California label approval for VENERATE CG in the near future,” said Lisa Malabad, Cannabis Segment Lead at Marrone Bio Innovations. “We look forward to helping growers and distributors integrate our innovative, effective and safe products into their indoor and outdoor growing operations across the state.”

About Marrone Bio Innovations
Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies to rapidly develop seven effective and environmentally responsible pest management products to help customers operate more sustainably while uniquely improving plant health and increasing crop yields. Supported by a robust portfolio of over 400 issued and pending patents around its superior natural product chemistry, MBI’s currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven® Stargus®, Amplitude™, Zelto® and Zequanox®.

Marrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for farmers, turf managers and consumers around the globe. For more information, please visit www.marronebio.com.

Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding the potential of Grandevo CG and Regalia CG and other MBI products, market projections, including the potential benefits of Grandevo CG and Regalia CG. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company's control that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the MBI’s products, any difficulty in marketing MBI’s products in its target markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of current information, future events or otherwise.

Lisa Malabad
Marrone Bio Innovations
5307502800
email us here


Source: EIN Presswire

10 Skills You Need to Become a Successful Lab Manager

Lab managers working

Lab managers working

Formaspace laboratory phenolic tops

Formaspace laboratory phenolic tops

Are you a current lab manager or looking to become one? Read some of our tips on how to be successful in your career!

In larger organizations, the lab manager may have to interface with dedicated purchasing staff members”

— Formaspace

AUSTIN, TEXAS, UNITED STATES, July 26, 2018 /EINPresswire.com/ — As a provider of unique furniture solutions to laboratory facilities at major Fortune 500 companies for over 35 years, Formaspace has developed unique insights into the best practices used in today’s modern lab facilities. One key observation is the increasingly important (and diverse) role of laboratory managers.

Over the past 35 years that Formaspace has been working directly with Lab Managers, we’ve seen a lot of changes in the industry. Indeed, today’s lab managers wear multiple hats that require them to develop a broad set of effective management skills — ranging from chief problem solver to team facilitator.

If you are contemplating a career move into laboratory management or know someone that is, we’ve compiled a list of the top 10 effective management skills that every laboratory manager should master.

Let’s get started:

1. Laboratory Managers Need to Be Good Business and Project Managers

Overview: Don’t get us wrong. We’re not saying scientific research has to be all business (some of the best discoveries have been made in unorthodox ways). Instead, we’re saying that the role of laboratory management is to provide services to the investigators in a reliable businesslike manner, in order to provide seamless support for scientific research (or related services functions, such as in the case of IT labs).

Scope of Activities: Establish a vision and mission with both detailed short-term plans as well as long-term plans (5+ years out) that track progress on specific project goals, time management, and budgetary issues, such as income sources, spending, salaries.

Recommendations: Lab Managers overseeing large laboratory settings (in universities, government or healthcare / pharma) might benefit from business classes or an MBA in order to manage complex budgets and other requirements. Certification from PMI as a Project Management Professional (PMP) could also be helpful. Countless books, seminars, and online classes teach business management skills. If you are new to all this, then The One Minute Manager and Putting First Things First are two resources to look into.

2. Laboratory Management Typically Oversees Acquisition of Capital Equipment, Purchasing of Supplies and Services, and Inventory Control

Overview: In a small laboratory environment, much of this work will fall directly on the lab manager, who may be directly responsible for allocating budgetary funds (from a research grant for example). In larger organizations, the lab manager may have to interface with dedicated purchasing staff members. In either case, it’s important to adhere to rigorous government* policies that regulate service contracts as well as asset acquisition, use, and disposition activities.

(*Government contracts may require sourcing from vendors, like Formaspace, that are listed on GSA purchasing schedules.)

Scope of Activities: Set spending priorities during each budgetary cycle; identify requirements for capital equipment; investigate vendor options; ensure timely ordering procedures for consumable supplies (including bidding out if required); establish service contracts (such as for disposing of hazardous wastes); negotiate with the company or institution hosting the lab over assigned overhead costs to be borne by your budget; set up inventory tracking and control system as well as establish procedures to protect valuable or potentially dangerous assets from misuse or theft.

Recommendations: In addition to the recommendations for business and project management, new laboratory managers might look into taking classes in purchasing management. If you are working with the government or military, look for online seminars and guides (from the GAO, GSA, etc.). Establishing friendly contacts with the purchasing department of your company or institution early on is also a good idea (rather than waiting until there is a confrontational issue at hand). Ideally, you will be able to find a mentor who can help you understand the ins and outs of rules and procedures already in use at your institution or company.

3. Laboratory Managers Need to Develop Effective Management Skills in Public Relations and Internal Communications

Overview: Do you wonder why some laboratories always seem to be promoted in the news, or they have widespread support throughout the entire organization? Conversely, have you witnessed reports of laboratory errors or accidents that made the news and put the lab in the worst possible light? These are just two examples of how good (and bad) public relations and internal communications programs can affect your laboratory workplace.

Scope of Activities: Public Relations generally refers to a wide range of communication programs directed outside the organization (from community relations, to press coverage, to trade fairs), while internal communications programs are directed at internal audiences (to educate and promote positive awareness of your activities). Depending on the size of your organization, you may need to liaise with existing communications teams (or external agencies), or you may need to develop these resources yourself.

Recommendations: Generally speaking, having a robust external and internal communications program (assuming your work is not classified or a trade secret) will help win over support for activities taking place in your lab (which can be very useful at budget allocation negotiations). Working with your existing communications team (if any), you should consider hosting press events, public tours (if appropriate), provide useful press releases and social media postings to gain local (if not national) coverage. Consider providing media training to lab researchers (such as lead investigators) to improve their ability to communicate in language that targeted audiences can understand — using video recordings for feedback sessions can be very useful. Practice in advance how you would respond to a crisis (such as an accident or another adverse incident) by conducting realistic dry runs on how to communication with the press during that time. Make sure you know the private cell numbers of key administration staff who will need to be looped in at short notice.

4. Laboratory Management is Often in Charge of Education and Staff Development Programs for the Lab Team

Overview: Face-to-face meetings at scientific conferences, scientific journal subscriptions, and training classes are a few examples of education and staff development programs that will help lab team members grow in their field while improving morale at the same time.

Scope of Activities: Participation in most education and development programs (such as conferences and training classes) should be planned far in advance. Managers will need to identify and prioritize which activities and purchases will provide the most benefit for the lab — as well as make judicious choices for who will participate. Associated costs — ranging from time away from the lab to subscriptions, tuition, admission and travel expenses — will need to be budgeted for in advance.

Recommendations: Joining the relevant scientific or trade associations that govern your lab’s area of interest is a good place to start. Don’t overlook participation in standards committees or governing boards (if relevant) if you are looking for ways for your team members to network or raise your organization’s profile. Identifying mentors who can provide guidance to lab team members is another good approach. If travel expenses are an issue, but you have good facilities for hosting guests at your company or institution, consider creating your own event to bring relevant experts to your facility (this is an ideal initiative for lab interns to organize and run).

5. Successful Laboratory Managers Need to Learn How to Write and Administer Grants as Well as Protect Intellectual Property (IP)

Overview: As funding for major government-sponsored scientific grant programs faces further budgetary cutbacks, competition for limited grant monies has never been tighter. At the same time, there is increasing emphasis on the value of licensing Intellectual Property (IP) derived from important scientific discoveries.

Scope of Activities: As a laboratory manager, you may need to oversee grant writing activities; for many laboratories, the future of the lab itself may be on the line if funding sources cannot be identified. In cases where grants are awarded, the lab manager may also have some level of responsibility for administering the grant, including certifying that research activities are in compliance with the applicable statutory governance requirements before grant monies are issued. Protecting Intellectual Property (IP) is another responsibility that may require the lab manager’s oversight. Tasks here can range from making sure that the lead investigator’s scientific notebooks are secured and documented properly as well as interfacing with IP attorneys or technology transfers teams (now common at many research universities) who may seek to license valuable scientific discoveries.

Recommendations: Many Lab Managers will turn to grant specialist to write grant applications as well as manage grant funding, which may require adherence to proper accounting procedures and issuance of timely reports. Successful grant writing is a skill that can be learned with time; serving on a grant selection committee (many positions are open to the public) is an ideal way to learn about the grant evaluation and award process from an insider’s perspective. Reach out to your institution’s Intellectual Property team to learn the best practices for protecting scientific discoveries and maximizing licensing opportunities, if applicable.

6. Laboratory Management Typically Interfaces Directly with Infrastructure and Facility Management Teams

Read more … https://formaspace.com/articles/laboratory-furniture/how-to-be-a-successful-lab-manager/?utm_source=einpresswire&utm_medium=content&utm_campaign=article-041817

Brooke Turner
Formaspace
8002511505
email us here


Source: EIN Presswire

Specialty Enzymes Market – World Specialty Enzymes Industry 2018- 2023

Specialty Enzymes Market

Specialty Enzymes Market By Source, By Type, By Application, and By Region – Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Recent past has witnessed a tremendous growth of Specialty Enzymes due to their augmented use in pharma and biotech industries.”

— Lead Analyst @ Market Data Forecast

HYDERABAD, TELANGANA, INDIA, July 26, 2018 /EINPresswire.com/ — Proteins play a vital role in the human body and responsible for many changes in different tissues and organs. Enzymes are a kind of proteins that are helpful in many processes of the living organisms. Metabolism to respiration to waste discard to tissue management, enzymes play a vital role in the body. Lack or reduced enzyme capability may result in some severe ailments like heart diseases, infections, pain at different places, immunity degradation, digestion problems, and even cancer in some cases. These enzymes mostly fight with the deeper roots of any problem providing the complete cure in many critical illnesses. Whereas, Specialty enzymes are mostly living creatures secreted natural proteins used in the pharmaceutical and biotechnology industries to boost the chemical transformations.

Specialty enzymes are by far called as biocatalysts that can help in the development of several drugs by transforming the chemical compounds in the pharma industry. These kinds of enzymes are widely used in the DNA management, genetic engineering and other fields of molecular biology. The specialty enzymes used in several drugs are helpful in treating many diseases like cancer and HIV.

Request for sample: https://www.marketdataforecast.com/market-reports/specialty-enzymes-market-3604/request-sample

The recent past has witnessed a tremendous growth of specialty enzymes due to their augmented use in pharma and biotech industries. Some of the growth factors driving their global market are demand for enzyme replacement therapies, use of biocatalysts in chemical components, increasing significance of systemic enzymes, usage of pharmaceuticals, more digestion related ailments, advent of many new companies in the market, advancements in enzyme production, surge of diagnostic enzymes, new innovations with the rise of technology, and so on.

On the contrary, the requirement for trained professionals, safety-related concerns for the storage, the lack of awareness among people, temperature constraints, availability of low price alternatives, expensive technology, and many other factors tend to inhibit the global specialty enzymes market extension.

To know more get our full report at https://www.marketdataforecast.com/market-reports/specialty-enzymes-market-3604/

The full report provides all the information needed for the global specialty enzymes market along with the segregation of markets on the basis of type, application, source and geographical regions.

On the basis of type, the market is separated into
• Carbohydrase
• Protease
• Polymerase and Nuclease
• Lipase

The polymerase and nuclease segment is anticipated to have the greater market revenue and expected to grow similarly in the forecast period.

On the basis of application, the market is separated into
• Pharmaceuticals
• Diagnostics
• Research & biotechnology
• Bio-catalyst

The pharmaceuticals market with the rising chronic diseases and elderly population occupies the leading position in market share and expected to continue the same trend in years ahead.

On the basis of source, the market is separated into
• Animals
• Microorganisms
• Plants

As per the market research analysis, the animal-derived enzymes are expected to at an annual growth rate close to 10.5% in the report mentioned forecast period.

On the basis of regional distribution, the market is separated into
• Europe
• North America
• Middle East and Africa
• Latin America
• Asia Pacific

North America holds the principal market share for global specialty enzymes closely followed by Asia Pacific markets and predicted to hold more than 46% of market share by 2025. Asia Pacific is estimated to grow at a CAGR of around 12% during the prescribed time frame. US contributes a commanding market share to the North America region.

The competitive landscape is also portrayed in the full report and some of the market leaders in the industry include
• Genzyme Corporation
• Amano Enzyme, Inc.
• Advanced Enzyme Technology Ltd.
• The Soufflet group
• Sanofi S.A
• Affymetrix Inc.
• National Enzyme Company
• Life Technologies
• Codexis Inc.
• F Hoffman-La Roche Ltd and others

Recent trends in the market include technology licensing agreement between GSK and Codexis, distribution deal between Novozymes and China National Pharmaceutical Foreign Trade, acquisition of Enzyme solutions by Connell Brothers, introduction of GingisKhan by Genovis AB, and others reveal a promising growth for the global specialty enzymes market in the future irrespective of several odds restraining the expansion.

Download Free sample @ Feed Enzymes Market, Baking Enzymes Market

About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

Sai Kutumbarao
Market Data Forecast
7680952236
email us here


Source: EIN Presswire

Signature Management and enhanced Stealth to be discussed at Future Armoured Vehicles Survivability conference

SMi reports: Optimising threat detection through signature management and enhanced sensor capabilities to be discussed at Future Armoured Vehicles Survivability

LONDON, WATERLOO, UNITED KINGDOM, July 23, 2018 /EINPresswire.com/ — SMi reports: Optimising threat detection through signature management and enhanced sensor capabilities to be discussed at this year’s Future Armoured Vehicles Survivability conference

Avoiding detection with increased stealth and enhanced signature management is imperative on the battlefield. Reducing the signature of armour is of increasing importance, particularly when the technology of adversaries is becoming more advanced. With this in mind, the 4th annual Future Armoured Vehicles Survivability, taking place this year on 13 – 15 November in London, will host presentations from senior experts from the Netherlands and Sweden on this very topic.
Featured presentations and their respective expert speakers:

Captain Mark Hoving, Staff Officer, Royal Netherlands Army will present: "Optimising Threat Detection and Stealth with the Fennek Light Armoured Reconnaissance Vehicle"

• Supporting land operations with the through enhanced reconnaissance capabilities
• The reconnaissance role of Fennek within mechanised force structure
• Ensuring survivability with optronics: NBC protection, night vision, thermal, CCD day camera and laser rangefinder
• How recent upgrades of the Fennek and retrofitting to the latest JFST 1A3+ version will enhance reconnaissance capabilities, ultimately improving survivability in deployments

Dr. Hans Kariis, Senior Researcher, Department of Antennas and Signatures, Swedish Defence Research Agency (FOI) will present: "How Signature Management and Enhanced Sensor Capabilities Support Crew and Vehicle Survivability"

• Optimising optronic sensor performance for threat detection purposes
• Functioning and delivering results in an environment of interference
• How radars and optics with advanced image and signal processing support timely threat detection and neutralisation
• Feedback and lessons from recent signature management technologies testing at the FOI

This year’s two-day conference will also include an exclusive Active Protection Systems focus day taking place on the 13th November with over 12 expert military & industry sessions and 3+ hours of networking.

Exclusive event content such as the past attendees list, previous year presentations and the latest event brochure are available to download free on the event website. Register your place at www.favsurvivability.com/einpr by the 28th September and receive a £100 discount on your booking.

Gold Sponsor: Leonardo
Sponsored by: Frazer Nash Consultancy, Lockheed Martin, Rheinmetall Active Protection GMBH, Soucy Defence and UTC Aerospace Systems

Past sponsors of the event include: Advance Blast and Ballistic System, Alcoa Defense, AmSafe Bridport, Arconic, Artec, BMT Cadence, CeramTec, FNSS, Horstman Defence Systems, Intermat, Isoclima, Leonardo, Metravib-Acoem, Microflown AVISA, Morgan Advanced Materials, Nexter Systems, Photonis, Pleora Technologies, Proengin, RADA, Rafael Advanced Defence Systems, Raytheon, Revision Military, Rheinmetall, Rheinmetall Waffe Munition, Saab, Skydex Technologies, Soucy Group, UTC Aerospace Systems and more.

To join the sponsor line-up and have the chance to exhibit, please contact Sadia Malick at smalick@smi-online.co.uk

Future Armoured Vehicles Survivability
APS Focus Day: 13th November 2018
Conference: 14th – 15th November 2018
London, UK
www.favsurvivability.com/einpr

—ENDS—
For delegate queries please contact James Hitchen at jhitchen@smi-online.co.uk
For media queries please contact Natasha Boumediene at nboumediene@smi-online.co.uk.

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Natasha Boumediene
SMI
2078276020
email us here


Source: EIN Presswire

Symphony response to BBC coverage

Whilst the BBC's coverage did not fairly represent the scientifically proven benefit of oxo-biodegradable technology. We are pleased to be focusing on solutions

Symphony Environmental Technologies plc (LSE:SYM)

Whilst the BBC’s coverage did not, in our opinion, fairly present the scientifically proven benefit of oxo-biodegradable technology, we are pleased that the BBC has now focused on the solution”

— Michael Laurier, CEO

LONDON, UNITED KINGDOM, July 20, 2018 /EINPresswire.com/ — SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

("Symphony" or the “Company”)

Response to BBC Coverage

Symphony Environmental Technologies Plc (AIM:SYM), a global specialist in technologies that “make plastics smarter”, makes the following statement on the coverage of its d2w plastic technology on the BBC news yesterday (19 July).

The Company’s Chief Executive, Michael Laurier said:

“Nearly all previous media coverage has been about the problem of plastic in the open environment, rather than the solution. Whilst the BBC’s coverage did not, in our opinion, fairly present the scientifically proven benefit of oxo-biodegradable technology, we are pleased that the BBC has now focused on the solution, and introduced our Company and our d2w technology to a much wider audience.

All plastics will fragment when exposed in the open environment, but the problem with ordinary plastics is that their fragments will lie or float around for decades before becoming biodegradable, and will persist and accumulate as a problem for future generations. During that time, they break down into microplastics and may attract and carry toxins.

Symphony’s d2w technology was invented to accelerate the degradation process and reduce the dwell-time of plastic in the environment, by adding a catalyst which promotes oxidation and converts the plastic into biodegradable materials. It is essential to understand that it does not just create fragments. d2w plastic can be recycled if collected but degradation followed by biodegradation is there to protect the environment if all else fails.

It is legitimate for the BBC reporter to question whether d2w technology actually works. To answer that question for ourselves and our customers we have commissioned scientific tests over more than 20 years so as to be quite sure that we would not be making misleading claims.

Based on this evidence a d2w plastic product will become biodegradable if exposed to oxygen on land or sea much more quickly than ordinary plastic.

These tests included successful exposure in seawater at the Bandol laboratory in France, and subsequent testing at Queen Mary University, London. We were therefore surprised when Richard Thompson of Plymouth University produced a bag which he claimed had failed to degrade. Mr. Thompson is not a polymer scientist, and we were given no opportunity before the broadcast to investigate his claim.

As previously reported by Symphony it is correct that the EU Chemicals Agency (“ECHA”) is studying “oxo-degradable” plastic at the request of the EU Commission. We welcome this, and have submitted detailed evidence to ECHA that “oxo-degradable” plastic is not the same as “oxo-biodegradable” plastic and that d2w plastic will fully biodegrade within a reasonable time and much more quickly than ordinary plastic into non-plastic biodegradable materials that will themselves naturally biodegrade in a similar way to a leaf.

The programme showed d2w plastic products being used in the Ivory Coast, where the government is concerned that plastic litter which gets into the environment should not lie or float around for decades. They, like several other governments across the world, are encouraging the use of d2w. Plastic is essential to the people of the Ivory Coast for protecting their food and water from contamination. A plastic ban could cause an epidemic and is most unlikely, therefore an alternate solution such as d2w is required.

We hope that the item on BBC news yesterday is the beginning of an open and honest debate about innovative solutions such as d2w. It is time to stop talking about the problem, and to focus on the solutions, for which d2w is one of a suite of Symphony’s technologies that we encourage governments and corporates to adopt.”

-ENDS-

Paula Hickford
Symphony Environmental Ltd
+44 (0) 208 207 5900
email us here


Source: EIN Presswire

VaporBrands CFO ElenorHodge Named interim CEO Following the Passing of CEO James Hodge

Elenor Hodge VaporBrands CFO has been appointed interim CEO following the passing of its CEO James Hodge earlier this month.

VapoBrands International, Inc. (OTCMKTS:VAPR)

The BOD has full confidence that until such time, the affairs of the organization as well as the initiatives set forth by James while at the helm, will continue to be met moving forward. ”

— VAPR Board of Directors

SPRING HILL , FLORIDA, UNITED STATES, July 18, 2018 /EINPresswire.com/ — VaporBrands International, Inc. (OTCPK:VAPR) announced that its CFO Elenor Hodge has been appointed interim CEO following the passing of its CEO James Hodge earlier this month. Elenor has been operating as the Company’s CFO and has worked closely with its now former CEO James Hodge throughout his tenure and will now officially fill his role as a result of his death earlier this month.
James Hodge had long been an executive CEO specializing in successfully re-building public Companies with a reputation for preserving investors well being, and cleaning up distressed companies. James was responsible for bringing all of VaporBrands filings current, re-establishing it as a viable business entity, and in forming partnerships with investors and strategic partners alike.
Elenor will remain in the role of interim CEO/CFO until the Company has identified and hired a permanent CEO. In the meantime, however, the Board of Directors has full confidence that until such time, the affairs of the organization as well as the initiatives set forth by James while at the helm, will continue to be met and move forward.

ABOUT VAPORBRANDS INTERNATIONAL (OTCPK:VAPR)
VaporBrands International, Inc. is a marketing and development partner for manufacturers of electronic cigarettes. Electronic cigarettes represent the future of smoking; they produce no smoke, tar, ash or offensive odor while containing about the same amount of nicotine as traditional tobacco cigarettes. Unlike traditional tobacco cigarettes, electronic cigarettes can be used in many public places currently restricted from smoking. VAPR intends to focus on creating opportunities for culturally relevant brands seeking to acquire significant market share in the rapidly growing "vaping" sector of the global marketplace.

Elenor Hodge
VaporBrands International. Inc.
000000000
email us here


Source: EIN Presswire

Utah Mesothelioma Victims Center Now Urges a Public Utility or Power Plant Worker with Mesothelioma in Utah to Call Them for Direct Access to the Nation's Top Lawyers for Better Financial Compensation Results

There is a direct connection between hiring the nation's most skilled, and experienced full-time mesothelioma attorneys and the person with mesothelioma receiving the best compensation result.”

— Utah Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, July 18, 2018 /EINPresswire.com/ — The Utah Mesothelioma Victims Center says, "We are appealing to a public utility, electric, water, or gas natural gas worker who has recently been diagnosed with mesothelioma in Utah to call us anytime at 800-714-0303 to ensure they are talking directly with some of the nation's most skilled and experienced mesothelioma attorneys. We specialize in assisting public utility and power/energy workers who have been diagnosed with mesothelioma in Utah and nationwide. Our number one priority is making certain people like this receive the very best possible financial compensation-which could exceed a million dollars." http://Utah.MesotheliomaVictimsCenter.Com

The Utah Mesothelioma Victims Center fears the Internet makes the process of getting direct access to the nation's top mesothelioma attorneys next to impossible. As the group would like to discuss anytime at 800-714-0303, "We only provide access to the nation's top mesothelioma attorneys who consistently get the best compensation for their clients. There is a direct connection between hiring the nation's most skilled, experienced, and capable full-time mesothelioma attorneys and the person with mesothelioma receiving the best possible financial compensation settlement result." http://Utah.MesotheliomaVictimsCenter.Com

For more information about public utilities in Utah including electric, natural gas, water and sewer please visit the State of Utah website: https://publicutilities.utah.gov/utillist-electric.html.

The Utah Mesothelioma Victims Center would like to emphasize theirs is a statewide initiative available to a diagnosed victim anywhere in Utah including communities such as Salt Lake City, Provo, West Jordan, Sandy Hills, Ogden, Saint George.

For the best possible mesothelioma treatment options in Utah the Utah Mesothelioma Victims Center strongly recommends the following heath care facility with the offer to help a diagnosed victim, or their family get to the right physicians at this hospital.

* The Huntsman Cancer Institute in Salt Lake City: http://healthcare.utah.edu/huntsmancancerinstitute/

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. However-mesothelioma does happen in Utah.

High-risk work groups for exposure to asbestos in Utah include US Navy Veterans, oil refinery workers, public utility workers, power plant workers, plumbers,pipefitters, electricians, auto mechanics, machinists, or construction workers. In most instances a diagnosed person with mesothelioma was exposed to asbestos in the 1950’s, 1960’s, 1970’s, or 1980’s.

The Utah Mesothelioma Victims Center says, “When it comes to obtaining the best mesothelioma settlement, the quality of the attorney matters, as we would like to explain anytime at 800-714-0303.”http://Utah.MesotheliomaVictimsCenter.Com

The Mesothelioma Victims Center is a national advocate 100% focused in on doing everything possible to ensure people with mesothelioma in every state receive the best possible financial compensation settlement. The group offers on the spot access to some of the nation’s most skilled and experienced mesothelioma attorneys because to receive the very best possible financial compensation a diagnosed person must be represented by the most capable mesothelioma lawyers in the United States as they would like to discuss anytime at 800-714-0303. http://MesotheliomaVictimsCenter.Com

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: http://www.nlm.nih.gov/medlineplus/mesothelioma.html

Michael Thomas
Utah Mesothelioma Victims Center
800-714-0303
email us here


Source: EIN Presswire

GateHouse Logistics and Cargo Chief Partner to Reduce Empty Miles and Enhance Service in the US Supply Chain

ghTrack integrated into Cargo Chief’s data streams alerts brokers and transport companies about empty trucks in specific areas that are ready to drive a load

Every year, American trucks travel at less than market rates or even empty for nearly half of their billion miles on our highways wasting fuel, time, labor and causing needless pollution”

— Russell Jones, CEO, Cargo Chief

NøRRESUNDBY AND MILLBRAE, DENMARK AND UNITED STATES, July 17, 2018 /EINPresswire.com/ — Supply chain data aggregation firm GateHouse Logistics and 3PL technology provider Cargo Chief today jointly announce a partnership that could see a nationwide network of more than 500,000 carriers reducing the number of empty runs on North American highways.

“Every year, American trucks travel at less than market rates or even empty for nearly half of their billion miles on our highways wasting fuel, time, labor and causing needless pollution,” says Russell Jones, Cargo Chief’s CEO. “By partnering with GateHouse Logistics, we can integrate its ghTrack technology into our data streams and provide brokers and transport companies with information in real time about trucks in specific areas that are intelligently paired with available loads to keep trucks rolling at reasonable rates.” Jones is also excited about ghTrack enabling highly accurate and ubiquitous tracking of all client truckload shipments.

“This partnership confirms the widespread applications of ghTrack technology in the logistics industry. Smart factories and their extended, just-in-sequence logistics are just a few examples and better capacity planning is yet another,” adds Jesper Bennike, CEO, GateHouse Logistics.

ghTrack is fully integrable as data-as-a-service, and its tracking and visibility data will enrich Cargo Chief solutions to provide accurate and relevant matches for freight planning.

About Cargo Chief
Cargo Chief unlocks hidden carrier capacity for 3PLs by leveraging patented, award-winning technology created by the combination of Silicon Valley ingenuity and deep freight industry expertise and relationships. Cargo Chief enables 3PLs to enhance their service and profitability by matching, booking and managing loads with their existing carriers more efficiently and effectively. Please visit www.CargoChief.com.

About ghTrack®
ghTrack is a completely neutral and independent cloud based data sharing service leading the way that business-critical data is securely shared across the entire supply chain. It is also the perfect foundation for emerging smart industries including IoT developments. ghTrack brings long-wanted, real-time end-to-end visibility to all stakeholders in the supply chain. It aggregates position and sensor data from all modes of transportation and presents them as one unified and logical data stream for simple integration into any business system. ghTrack is Europe’s most widely used and secure data sharing service and is fully GDPR compliant. ghTrack is a brand of GateHouse Logistics A/S. Please visit www.ghTrack.com.

Ends

Hugh Paterson
Whoosh PR
+447768175452
email us here


Source: EIN Presswire

Louisiana Mesothelioma Victims Center Now Urges Oil Refinery Workers with Mesothelioma in Louisiana to Call About Getting an "Attorney Upgrade" For a Much Better Client Financial Settlement Result

Mesothelioma compensation claims for oil refinery or oil production workers can frequently exceed one million dollars provided the diagnosed person has the nation's most skilled mesothelioma attorneys”

— Louisiana Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, July 11, 2018 /EINPresswire.com/ — The Louisiana Mesothelioma Victims Center says, "We specialize in assisting oil refinery or power plant workers who have been diagnosed with mesothelioma receive the very best financial compensation. We are advocates for people with mesothelioma and the attorneys we suggest are some of the nation's leading lawyers for financial compensation for this asbestos exposure cancer. As we would like to explain anytime at 800-714-0303 the attorneys we suggest do not get paid unless there has been a financial compensation settlement. http://Louisiana.MesotheliomaVictimsCenter.com

Up until recently, there had not been an oil refinery built in the US for roughly 30 years. Existing older plants possibly still have asbestos at the refinery. Prior to 1980, many oil refinery workers would have been exposed to asbestos constantly-especially if they were a plumber, electrician, fitter, insulator, or part of a maintenance or construction crew.

The group says, "If we had just one vital compensation tip for an oil refinery or oil/gas production worker with mesothelioma in Louisiana it would be this: call us at 800-714-0303 and take us up on our offer to upgrade you to one of the nation's most skilled and capable mesothelioma attorneys. These incredibly experienced mesothelioma attorneys will produce a much better compensation settlement result for you or your family member as we would like to discuss." http://Louisiana.MesotheliomaVictimsCenter.Com

"Mesothelioma compensation claims for oil refinery or oil production workers can frequently exceed one million dollars provided the diagnosed person has the nation's most skilled mesothelioma attorneys working on their financial compensation claim. If you have mesothelioma in Louisiana please call us anytime at 800-714-0303.” http://Louisiana.MesotheliomaVictimsCenter.Com

Top Locations for oil refineries in Louisiana include:

* Baton Rouge
* Chalmette
* Lake Charles
* Garyville
* Shreveport
* Convent
* Belle Chasse
* Meraux

For more information about recent construction of oil refineries in the US, please refer to the US Energy Information Administration's website: https://www.eia.gov/tools/faqs/faq.cfm?id=29&t=6

The Louisiana Mesothelioma Victims Center wants to emphasize there is a statewide initiative available to a diagnosed victim anywhere in Louisiana including communities such as New Orleans, Baton Rouge, Shreveport, Lafayette, Lake Charles, Kenner, Bossier City, Monroe.

When it comes to treatment options for mesothelioma in Louisiana the Louisiana Mesothelioma Victims Center strongly encourages diagnosed victims to contact the following cancer treatment centers in Louisiana, and in Texas. Note: The MD Anderson Cancer Center in Houston, Texas may be one of the most capable mesothelioma treatment centers in the world: Oshner Cancer Institute New Orleans; http://www.louisianacancercenter.org/research/partners/ochsner/, The MD Anderson Cancer Center Houston, Texas: https://www.mdanderson.org/

High-risk work groups for exposure to asbestos in Louisiana include Veterans of the US Navy, power plant workers, shipyard workers, oil refinery workers, chemical plant workers, public utility workers, factory workers, plumbers, electricians, insulators, auto mechanics, machinists, and construction workers. Typically, the exposure to asbestos occurred in the 1950’s, 1960’s, 1970’s, or 1980’s. http://Louisiana.MesotheliomaVictimsCenter.Com

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon.

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma.

Michael Thomas
Louisiana Mesothelioma Victims Center
800-714-0303
email us here


Source: EIN Presswire